We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7% Neuren s...
Read ArticleStockhead’s Sarah Hughan sits down with Aroa Biosurgery’s (ASX:ARX) founder and CEO Brian Ward to ge...
Read ArticleThe ASX fell on new expectations for rate cuts All 11 ASX sectors fell, with real estate and hea...
Read ArticleMixed revenue trends emerge from the latest batch of quarterly updates Proteomics plans to launch i...
Read ArticleAroa looks to capitalise on growing US wound-care market forecast to reach US$13 billion by 2034 Co...
Read ArticleStockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of th...
Read ArticleWhat is regenerative healing? Why are such healing products used? And where does AROA sits in the gr...
Read ArticleWhat is regenerative healing? Why are such healing products used? And where does AROA sits in the gr...
Read ArticleGiven the strong potential returns on offer at the small end of the market, it could be worth adding...
Read ArticleASX 200 nears 8,000 points, boosted by mining stocks Monadelphous and Baby Bunting rose; Yancoal an...
Read ArticleAroa focused on expanding clinical evidence to support use of its ECM products in soft tissue repai...
Read ArticleASX health stocks rise 0.8% past five days as broader market lifts 3.7% Morgans says ProMedicus ‘p...
Read ArticleThe 2024 Bioshares Biotech Summit being held in Fremantle from July 12-13 Morgans says conference l...
Read ArticleLooking for exposure to the healthcare sector in FY 2025? If you are, then check out the three ASX s...
Read ArticleIf you're not averse to investing at the small side of the market, then it could be worth checking o...
Read ArticleAROA Biosurgery continues to expand its product line in regenerative tissue repair on back of posit...
Read ArticleASX health stock fall in past five days along with broader markets Sonic Healthcare cuts FY24 profi...
Read ArticleStockhead’s Sarah Hughan sits down with AROA Biosurgery (ASX:ARX) founder and CEO Brian Ward to get...
Read ArticleTech stocks surged on ASX today, offset by losses in Mining stocks Gold and copper hit all-time hig...
Read ArticleSoft tissue repair company Aroa Biosurgery FY24 revenue grows 12% yoy to NZ$69.1 million Myriad re...
Read ArticlePositive net cash inflows from operations of NZ$300k, exceed Q4 breakeven expectations Strong cash...
Read ArticleThe ASX inched higher on Tuesday ahead of the Fed’s rates call Lithium stocks flashed green today A...
Read ArticleS&P/ASX 200 Health Care (ASX: XHJ) shares are up 0.44% on Tuesday while the ASX 200 is up 0.23%....
Read ArticleAroa Biosurgery focuses on transitioning operations to cashflow positive in FY25 US distribution pa...
Read ArticleThe ASX200 has ended Friday down 0.15pc, but ends week higher Property and Healthcare gains offset...
Read ArticleStockhead’s Ashtyn Hiron sits down with AROA Biosurgery (ASX:ARX) CEO Dr. Brian Ward to get the shor...
Read ArticleASX health sector up in line with broader market but some names ail after quarterly results Cochlea...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleAROA reports 80% increase in sales of high-margin Myriad in H1 FY24 TELA Bio’s sales of OviTex and...
Read ArticleMorgans releases its ASX wound care report seeing value in Aroa Biosurgery, Avita Medical and PolyN...
Read ArticleAroa Biosurgery maintains product revenue guidance for FY24, up 25-30% on FY23 Company’s US commerc...
Read ArticleASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports re...
Read ArticleAroa Biosurgery forecasts business growth of up to 30% annually with product revenue guidance of NZ...
Read ArticleASX health sector falls in line with broader markets on macroeconomic factors and global geopolitic...
Read ArticleASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Cli...
Read ArticleASX health stocks fall 1.82% in the past five days in line as broader markets rise slightly Resmed...
Read ArticleASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes mo...
Read ArticleASX health stocks up 1% in the past five days in line with broader markets Volpara records third qu...
Read ArticleASX health stocks outperforming the broader market but remain flattish for week Several ASX health...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a tough time on Tuesday. In afternoon trade, the be...
Read ArticleBiotech Aroa has released its audited results for the 2023 financial year, hitting targets and achie...
Read ArticleThe market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts...
Read ArticleASX health stocks have fallen in the past five days in line with broader markets Volpara Health Tec...
Read ArticleThere could be big returns lurking at the small end of town according to analysts at Morgans. Here’...
Read ArticlePharmaxis widens clinical trial following FDA guidance Aroa receives US FDA 510K clearance Cynata g...
Read ArticleASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% af...
Read ArticleThe health sector is seen by many experts as one that could remain resilient through times of econo...
Read ArticleSeveral ASX health stocks are seeking US FDA approval for drugs/devices in the near future Telix P...
Read ArticleASX health stocks fall 1.75% for the past five days Several companies announce successful capital r...
Read ArticleThe All Ordinaries Index (ASX: XAO) is back in the green on Wednesday, driven higher by four shares...
Read ArticleThe All Ordinaries Index (ASX: XAO) is wobbling in and out of the green on Tuesday, but its volatil...
Read ArticleTuesday is shaping up to be rough one for many All Ordinaries Index (ASX: XAO) shares. Fortunately,...
Read ArticleAnalysts at Wilsons have put the spotlight on one All Ordinaries Index (ASX: XAO) share it prefers...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has faded in afternoon trade but remains on course to record...
Read ArticleIt’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with...
Read ArticleFranklin Templeton says innovation accelerates despite recessions, pandemic, wars Expect advancemen...
Read ArticleWhile there are many successful companies on the ASX that solely serve Australian consumers, there...
Read ArticleWith so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleAvita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is pop...
Read ArticleDark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleWith COVID-19 Omicron surging around the globe, ASX healthcare shares are back in the spotlight. Wh...
Read ArticleAfter a difficult 2021, the Polynovo Ltd (ASX: PNV) share price has bounced 13% this morning after t...
Read ArticleThere aren’t too many ASX shares that can lay claim to a 10 bagger return in less than 2 years, and...
Read ArticleIt was a mixed bag of results for ASX healthcare shares as we walked through October, as some names...
Read ArticleAfter a positive start the ASX finished down over 0.5%. Today, APRA ordered the big banks to increas...
Read ArticleThe Aroa Biosurgery Ltd (ASX: ARX) share price is climbing in early trade this morning as the compa...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which...
Read ArticleEarlier this week the Pinnacle Investment Summit was held and a number of ASX fund managers outlined...
Read ArticleThe cavalcade of life science initial public offers (IPOs) and ASX listings shows few signs of reced...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleInvestor funds continue flowing into ASX listed biotechnology shares this year, with a total of alm...
Read ArticleSoft-tissue regeneration company Aroa Biosurgery (ASX:ARX) has announced the successful comp...
Read ArticleThe ASX tech sector succumbed to the latest selloff in tech equities globally. dragging the rest of...
Read ArticleThe ASX 200 touched intraday record highs, but could not hold on and closed the day just shy of its...
Read ArticleThe fortunes of ASX healthcare shares can often swing on one momentous milestone. Examples of such...
Read ArticleA recent article published in the Advance Science magazine discussed research by Monash University t...
Read ArticleThe Aroa Biosurgery Ltd (ASX: ARX) share price is on the move on Tuesday morning. At the time of wr...
Read ArticleThe ASX picked up where it left off before the Easter break with another day of gains. The ASX 200 r...
Read ArticleThe Aroa Biosurgery Ltd (ASX: ARX) share price is up 2.6% after the company shared positive news th...
Read ArticleSource: Monster Ztudio, Shutterstock Summary Allegra Orthopaedics has reported completing the 8...
Read ArticleSoft-tissue regeneration company Aroa Biosurgery (ASX:ARX) has announced the US FDA has gran...
Read ArticleASX mid-cap healthcare company Avita Medical Inc (ASX: AVH) released its second-quarter FY21 result...
Read ArticleShares in ASX healthcare company Polynovo Limited (ASX: PNV) almost doubled in price last year. And...
Read ArticleNew ASX stocks are beating the old in 2020 and some experts are predicting that this will trigger a...
Read ArticlePeter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa...
Read ArticleSoft-tissue regeneration company Aroa Biosurgery (ASX:ARX) says the Indian regulator has app...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) could be about to end its winning streak. T...
Read ArticleShares in soft tissue regeneration company, Aroa Biosurgery Ltd (ASX: ARX), are falling lower this...
Read ArticleOn Tuesday Pinnacle Investment Management Group Ltd (ASX: PNI) held its Pinnacle 2020 Virtual Summi...
Read ArticleSoft-tissue regeneration company Aroa Biosurgery (ASX:ARX) has provided an update it says hi...
Read ArticleThe sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have...
Read ArticleASX companies continued to raise money in July, with over $4bn shelled out by investors, taking 2020...
Read ArticleThe Aroa Biosurgery Ltd (ASX: ARX) share price has closed 7.69% higher today after announcing it ha...
Read ArticleShareholders in biological scaffold maker Aroa Biosurgery (ASX:ARX) got a double treat on Thursday m...
Read ArticleNewly-listed soft tissue regeneration company Aroa Biosurgery (ASX: ARX) has announced that its Symp...
Read ArticleAroa Biosurgery Ltd (ASX: ARX) knocked the lights out on its ASX opening day debut on Friday. The N...
Read ArticleThere are many reasons why a company might change its name, from being taken over to hiding a shady...
Read ArticleBase metals explorer Cyprium Metals (ASX: CYM) has reported positive results from a drilling campaig...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
